|
STATEMENT Barbara Loe Fisher, Co-Founder and
President
Parents and Citizens Committee to Stop
Medical Experimentation in D.C.
Just
15 days after the Centers for Disease Control recommended that all 11 and 12
year old girls in America get three doses of Merck’s HPV vaccine, GARDASIL,
the very first GARDASIL reaction report was filed with the federal Vaccine
Adverse Event Reporting system. The
report described a 14 year old District of Columbia girl, who was injected
with GARDASIL on
The
National Vaccine Information Center joins with the Parents and Citizens
Committee to Stop Medical Experimentation in D.C. in calling for public
hearings and citizen testimony about whether 11 year old girls living in the
nation’s Capitol should be required by law to get three doses of HPV vaccine
in order to attend sixth grade. This call for more citizen involvement in
new vaccine laws is taking place in every state where HPV vaccine mandates
are being aggressively pursued by drug company lobbyists and legislators
trying to force young girls to use HPV vaccine without the voluntary,
informed consent of parents.
Since 1982 the
First,
there is a serious absence of scientific evidence that Merck’s GARDASIL is
safe to give to young girls entering puberty, who are biologically different
from older women. Vaccine mandates target 11 year old girls but Merck only
studied the safety of GARDASIL in a few hundred eleven year old girls and
followed them up for a few years.
Already, there have been more than 600 reports made to the federal
Vaccine Adverse Event Reporting System documenting that young girls are
collapsing and suffering seizures, loss of sensation in the hands and feet,
vision and speech problems, Guillain Barre syndrome, facial paralysis, and
other serious neurological symptoms. Merck also admits in its product insert
that GARDASIL was not studied for the ability to affect female fertility,
cause other kinds of cancer or be toxic to the genes.
Second, there is little or no scientific evidence that
Merck’s GARDASIL will actually protect 11 year old girls from getting
cervical cancer. The vaccine
only contains two high risk HPV types out of 15 types associated with
cervical cancer.
Officials at the Food and Drug Administration and Centers for Disease
Control have expressed concern that the 13 other high risk HPV types could
replace the two types in
GARDASIL so that HPV associated cervical cancer may not, in fact, be
eliminated with widespread use of the vaccine.
Young girls may think they can skip routine pap smears because the
vaccine protects them from getting cervical cancer when that may not be true
at all.
Third, more than 90 percent of all girls and boys, who become infected with
HPV, asymptomatically clear the infection from the body. It takes many years
of chronic infection for undiagnosed pre-cancerous cervical lesions to
progress to cervical cancer, usually because the women have not had routine
cancer -detecting pap smears.
Cervical cancer has dropped by more than 74 percent in the
The more than $4 billion dollars it will take to
vaccinate every 11 year old girl in Washington, D.C. and every other state
could be better spent on research to find out why so many highly vaccinated
children in Washington, D.C. and other public school systems around the
nation are chronically ill and disabled, with 1 in 150 autistic, one in 6
learning delayed and millions more asthmatic and diabetic.
In conclusion, HPV vaccine mandates are unnecessary,
expensive and potentially dangerous because so little is known about the
long term health risks and effectiveness of Merck’s GARDASIL vaccine.
Elementary schools should be centers for learning and not centers for
forced use of potentially unsafe and ineffective vaccines. The |